首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1629816

全球动脉瘤夹市场 - 2024-2031

Global Aneurysm Clips Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年，全球动脉瘤夹市场规模达52.4亿美元，预计2031年将达到103.1亿美元，2024-2031年预测期间复合年增长率为8.9%。

动脉瘤夹是用于治疗脑动脉瘤的专用手术设备，脑动脉瘤是由大脑中受损的动脉血引起的隆起。这些夹子通常由钛製成，旨在在称为动脉瘤夹闭的外科手术过程中插入动脉瘤颈部。这些夹子的基本功能是将动脉瘤与正常血流隔离，有效地将其封闭并防止其充满血液。这项手术至关重要，因为动脉瘤破裂可能会导致严重后果，例如出血性中风，从而增加死亡或终身残疾的风险。

全球动脉瘤夹市场的主要驱动力是由于外科手术中对夹子的需求增加、脑动脉瘤盛行率的增加以及改进的钛合金在夹子中的使用。此外，夹子具有薄刀片形状，并且相容于 MRI，可保护组织完整性。虽然动脉瘤夹闭手术已被证明在治疗动脉瘤方面是安全有效的，但它是一种侵入性手术，需要全身麻醉和颅骨解剖。

市场动态：

驱动程式和限制

脑动脉瘤盛行率增加

脑动脉瘤盛行率的增加预计将成为全球动脉瘤夹市场成长的重要因素。脑动脉瘤盛行率的增加预计将对全球动脉瘤夹市场的成长产生重大影响。脑动脉瘤是指大脑动脉局部扩张，会造成严重的健康危害，包括破裂和随后出血的可能性。随着人们越来越意识到这些问题以及医疗技术的进步，对动脉瘤夹等有效治疗方案的需求预计将会增加。随着老年人口的不断增加和与生活方式相关的健康状况的增加导致发病率上升，除了手术设备的技术进步之外，预计未来几年对动脉瘤夹的需求将显着增加。

脑动脉瘤盛行率的增加是推动市场的主要因素。例如，根据脑动脉瘤基金会的统计，美国估计有 680 万人患有未破裂的脑动脉瘤，即每 50 人中就有 1 人患有未破裂脑动脉瘤。年破裂率约为每 10 万人 8 - 10 例。美国每年约有 3 万人遭受脑动脉瘤破裂。脑动脉瘤每 18 分钟就会破裂一次。全球每年有近50万人因脑动脉瘤死亡，其中一半的受害者年龄在50岁以下。

严格的监管要求

严格的监管要求等因素预计将阻碍全球动脉瘤夹市场。由于卫生当局实施严格的监管标准，全球动脉瘤夹市场面临相当大的障碍。美国FDA和欧洲EMA等监管机构对包括动脉瘤夹在内的医疗器材的安全性和有效性提出了严格的要求。这些法规要求在新产品推向市场之前进行全面的临床测试和详细的文件记录。这些审批流程的复杂性和冗长可能会抑制创新并延迟潜在有用产品的发布。高成本、冗长的授权程序以及与合规性相关的不确定性可能会阻碍创新并限制製造商的市场机会，特别是那些资源有限的製造商。

Aneurysm clips are specialized surgical devices used to treat brain aneurysms, which are bulges caused by damaged blood arteries in the brain. These clips are normally composed of titanium and are intended to be inserted across the neck of an aneurysm during a surgical procedure known as aneurysm clipping. The fundamental function of these clips is to isolate the aneurysm from normal blood flow, effectively closing it off and preventing it from filling with blood. This operation is critical because a ruptured aneurysm can cause serious consequences, such as hemorrhagic stroke, which increases the risk of death or lifelong disability.

The major driving forces global aneurysm clips market are due to increased demand for the clips in surgical operations, increasing prevalence of cerebral aneurysms and the usage of improved titanium alloys in the clips. Additionally, the clips have a thin blade shape and are MRI compatible, protecting tissue integrity. Although aneurysm clipping procedure has shown to be safe and effective in treating aneurysms, it is an invasive procedure that requires general anesthesia and dissection of the skull for the procedure.

Market Dynamics: Drivers & Restraints

Increasing prevalence of cerebral aneurysms

The increasing prevalence of cerebral aneurysms is expected to be a significant factor in the growth of the global aneurysm clips market. The increasing prevalence of cerebral aneurysms is expected to have a significant effect on the growth of the global aneurysm clips market. Cerebral aneurysms, which are defined by localized dilations in the blood arteries of the brain, pose serious health hazards, including the possibility of rupture and subsequent hemorrhage. As people become more aware of these concerns, and medical technology advances, the need for effective treatment options like aneurysm clips is projected to rise. With a growing elderly population and increased lifestyle-related health conditions contributing to greater incidence rates, in addition to technological advancemens in surgical equipment, demand for aneurysm clips is projected to increase significantly in the future years.

The increasing prevalence of cerebral aneurysms is the major factor that is driving the market. For instance, according to the Brain Aneurysm Foundation, an estimated 6.8 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. The annual rate of rupture is approximately 8 - 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. So, as a result of rise in the aneurysms, the demand for the aneurysm clips increases and drives the market.

Stringent regulatory requirements

Factors such as stringent regulatory requirements are expected to hamper the global aneurysm clips market. The global aneurysm clips market confronts considerable obstacles as health authorities apply severe regulatory standards. Regulatory authorities, such as the FDA in the United States and the EMA in Europe, set strict requirements for the safety and efficacy of medical devices, including aneurysm clips. These regulations require comprehensive clinical testing and detailed documentation before new products can be introduced to the market. The complexity and length of these approval processes can stifle innovation and delay the release of potentially helpful products. The high costs, lengthy authorization procedures, and uncertainties associated with compliance can hamper innovation and limit the market opportunity for manufacturers, particularly those with limited resources.

Segment Analysis

The global aneurysm clips market is segmented based on material type, aneurysm type, end-user and region.

Titanium based aneurysm clips segment is expected to dominate the global aneurysm clips market share

Titanium based aneurysm clips segment is expected to dominate the global aneurysm clips market share. The titanium-based aneurysm clips segment is expected to dominate the global aneurysm clip market due to a number of compelling features that highlight the material's distinct advantages. This dominance can be due to titanium's inherent characteristics, which make it ideal for medical uses, notably in neurosurgery. One of the key reasons for using titanium aneurysm clips is their biocompatibility.

Titanium is known for its inertness and non-reactivity, which reduces the possibility of negative reactions when implanted in the human body. This feature is critical in surgical situations because the clips must securely occlude blood arteries without triggering irritation or rejection by the body. In addition, the compatibility with imaging modalities, mainly CT scans, MRI, and X-rays, and its capability to effectively secure the closure of delicate vessels during treatment makes it a preferred option as surgical equipment, thus propelling the growth of the segment.

North America is expected to hold a significant position in the global aneurysm clips market share

North America is expected to maintain its dominant position in the global aneurysm clips market share. This position of prominence is primarily due to a combination of factors, including modern healthcare infrastructure, high aneurysm incidence rates, and significant investments in R&D. The region's well-established medical institutions are supplied with advanced equipment and competent workers, allowing for the widespread use of breakthrough surgical procedures and devices like aneurysm clips. For instance, according to the Brain Aneurysm Foundation, an estimated 6.8 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. African-Americans and Hispanics are about twice as likely to have a brain aneurysm rupture compared to caucasians.

Research and innovation are critical in sustaining North America's dominant position in the aneurysm clip business. The National Institutes of Health (NIH) has provided major capital for cerebrovascular disease research, which is likely to result in advances in aneurysm clip technology. These advancements not only improve therapeutic efficacy and safety, but also coincide with the emerging trend of minimally invasive surgical methods that are less traumatic to patients.

Asia Pacific is growing at the fastest pace in the global aneurysm clips market

Asia Pacific is experiencing the fastest growth in global aneurysm clips owing to the increasing incidence of brain aneurysms and technological advancements in the region. Technological innovations play an important part in moving the Asia Pacific aneurysm clips market ahead. Aneurysm removal procedures are now more effective and safer due to advances in surgical techniques and materials. The emergence of less invasive procedures has made surgery less stressful for patients while also improving recovery times. These developments are especially advantageous in densely populated areas, where access to surgical care can be limited. The increasing prevalence of brain aneurysms is also one of the major driving factor. For instance, according to an article published in the Times of India, India reports somewhere around 76,500 to 204,100 new cases of brain aneurysms every year.

Competitive Landscape

The major global players in the global aneurysm clips market include Boston Scientific, Medtronic, St. Jude Medical, Codman & Shurtleff, KLS Martin Group, InoMed, Integra LifeSciences, Mizuho America, Stryker Corporation, B Braun, RauMedic among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global aneurysm market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Material Type
3.2. Snippet by Aneurysm Type
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Cerebral Aneurysms
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Regulatory Requirements
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Material Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 6.1.2. Market Attractiveness Index, By Material Type
6.2. Titanium*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Cobalt
6.4. Others

7. By Aneurysm Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 7.1.2. Market Attractiveness Index, By Aneurysm Type
7.2. Cerebral*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Thoracic
7.4. Abdominal
7.5. Peripheral

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals and Clinics*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Research Centers
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Boston Scientific*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Medtronic
11.3. St. Jude Medical
11.4. Codman & Shurtleff
11.5. KLS Martin Group
11.6. InoMed
11.7. Integra LifeSciences
11.8. Mizuho America
11.9. Stryker Corporation
11.10. B Braun

LIST NOT EXHAUSTIVE